302 - Growth Analysis in Children Aged 6 to 11 Years with Severe Atopic Dermatitis and Impact of 16 Weeks of Dupilumab Treatment on Height

Alan D. Irvine, Trinity College Dublin, Dublin, Dublin, Ireland; Amy S. Paller, Northwestern University The Feinberg School of Medicine, Wilmette, IL, United States; Elaine C. Siegfried, Saint Louis University, St. Louis, MT, United States; Michael J. Cork, Sheffield Dermatology Research, University of Sheffield, Sheffield, England, United Kingdom; Lisa A. Beck, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Zhen Chen, Sanofi, Tarrytown, NY, United States; Carlos Peralta, Sanofi, Amsterdam, Noord-Holland, Netherlands; Annie Zhang, Sanofi, Cambridge, MA, United States; Stephane Levy, Regeneron, Sleepy Hollow, NY, United States; Sonya L. Cyr, Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States